AIHealthcare Analytics

Knowledge Wiki

Wiki › FDA Seeks Public Input on Adaptive AI Medical Devices

FDA Seeks Public Input on Adaptive AI Medical Devices

OVERVIEW
Rev 1 Sep 8, 2026 14:06 UTC 1 sources

Overview Medical Daily reports that the FDA is seeking public input on AI medical devices capable of changing their outputs or recommendations over time — so-called "adaptive" or "continuously learning" AI devices. This represents a formal regulatory process to address one of the most challenging aspects of AI-enabled medical device governance. The Core Challenge Traditional medical device regulation assumes a fixed product: what was tested is what is authorized. Adaptive AI devices break this assumption by design, potentially improving performance over time but also potentially drifting in ways that introduce new risks. The FDA's public input process acknowledges that existing frameworks do not adequately address this dynamic. Implications for Governance Public input on adaptive AI devices has implications for post-market surveillance requirements, re-authorization triggers, and the responsibilities of both manufacturers and deploying health systems. The process may inform forthcoming FDA generative AI regulatory guidance. Industry Context This regulatory development is closely linked to the FDA's TEMPO pilot for generative AI devices and the broader evidence gap between FDA clearance and clinical validation of AI medical devices documented across multiple studies in 2026. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index